GILD
Gilead Sciences, Inc.
- Stock-based compensation, 2025
- $894M
- YoY, 2025
- +7.1%
- 5-year CAGR
- +6.8%
- 10-year CAGR
- +8.9%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $894M | +7.1% |
| 2024 | $835M | +9.0% |
| 2023 | $766M | +20.3% |
| 2022 | $637M | +0.3% |
| 2021 | $635M | −1.2% |
| 2020 | $643M | +1.1% |
| 2019 | $636M | −24.7% |
| 2018 | $845M | +32.4% |
| 2017 | $638M | +67.9% |
| 2016 | $380M | −0.5% |
| 2015 | $382M | +6.1% |
| 2014 | $360M | +42.9% |
| 2013 | $252M | +20.6% |
| 2012 | $209M | +8.6% |
| 2011 | $192M | −3.8% |
| 2010 | $200M | +10.7% |
| 2009 | $181M | +17.8% |
| 2008 | $153M | −16.9% |
| 2007 | $185M | — |